Maximus, Inc. (NYSE:MMS – Free Report) – Research analysts at Zacks Research lifted their Q1 2025 EPS estimates for shares of Maximus in a report issued on Wednesday, December 11th. Zacks Research analyst R. Department now forecasts that the health services provider will earn $1.39 per share for the quarter, up from their prior estimate of $1.38. The consensus estimate for Maximus’ current full-year earnings is $5.89 per share. Zacks Research also issued estimates for Maximus’ Q2 2025 earnings at $1.44 EPS, Q3 2025 earnings at $1.50 EPS, Q4 2025 earnings at $1.52 EPS, FY2025 earnings at $5.84 EPS, Q2 2026 earnings at $1.19 EPS, Q3 2026 earnings at $1.45 EPS, Q4 2026 earnings at $1.23 EPS, FY2026 earnings at $5.05 EPS and FY2027 earnings at $5.29 EPS.
Separately, StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a research report on Thursday, November 28th.
Maximus Price Performance
MMS opened at $69.85 on Friday. The company has a 50 day moving average of $82.58 and a two-hundred day moving average of $86.59. Maximus has a 52-week low of $69.72 and a 52-week high of $93.97. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. The company has a market cap of $4.21 billion, a P/E ratio of 13.97 and a beta of 0.73.
Institutional Trading of Maximus
A number of institutional investors and hedge funds have recently modified their holdings of MMS. Inspire Advisors LLC raised its stake in Maximus by 1.4% during the second quarter. Inspire Advisors LLC now owns 8,768 shares of the health services provider’s stock worth $751,000 after acquiring an additional 121 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Maximus by 4.5% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider’s stock worth $272,000 after purchasing an additional 136 shares during the last quarter. Petrus Trust Company LTA boosted its position in Maximus by 2.7% during the 3rd quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider’s stock valued at $660,000 after purchasing an additional 185 shares during the period. WR Wealth Planners LLC grew its stake in Maximus by 4.6% during the 2nd quarter. WR Wealth Planners LLC now owns 4,525 shares of the health services provider’s stock worth $388,000 after buying an additional 198 shares during the last quarter. Finally, Holocene Advisors LP increased its position in Maximus by 6.5% in the third quarter. Holocene Advisors LP now owns 3,927 shares of the health services provider’s stock worth $366,000 after buying an additional 239 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Maximus
In related news, insider Michelle F. Link sold 1,363 shares of the company’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total transaction of $126,159.28. Following the sale, the insider now directly owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. This represents a 17.19 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Raymond B. Ruddy acquired 3,490 shares of Maximus stock in a transaction that occurred on Thursday, December 12th. The shares were purchased at an average price of $71.46 per share, for a total transaction of $249,395.40. Following the completion of the purchase, the director now directly owns 112,520 shares of the company’s stock, valued at $8,040,679.20. The trade was a 3.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.40% of the stock is currently owned by corporate insiders.
Maximus Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, November 15th. This represents a $1.20 annualized dividend and a yield of 1.72%. Maximus’s dividend payout ratio is presently 24.00%.
About Maximus
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
- Five stocks we like better than Maximus
- Quiet Period Expirations Explained
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- What is a support level?
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- How to Use the MarketBeat Dividend Calculator
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.